About
RNA Therapeutics
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
105
By Phase
PHASE1: 1PHASE2: 1
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05986240Collaborator
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
PHASE1Recruiting
24 participants
Started: May 8, 2024 · Completed: Jul 31, 2028
NCT05814666Lead Sponsor
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
PHASE2Recruiting
81 participants
Started: May 30, 2023 · Completed: May 30, 2026
Locations (1)
Headquarters
Leuven, Belgium
Map
Loading map...